323 related articles for article (PubMed ID: 31606939)
1. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
Shin J; Lee JS; Hann SK; Oh SH
Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
[No Abstract] [Full Text] [Related]
4. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
5. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo.
El-Zawahry BM; Bassiouny DA; Sobhi RM; Abdel-Aziz E; Zaki NS; Habib DF; Shahin DM
Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):84-90. PubMed ID: 22409711
[TBL] [Abstract][Full Text] [Related]
8. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
[TBL] [Abstract][Full Text] [Related]
9. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
Kaur A; Barman KD; Sahoo B; Choudhary P
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
[TBL] [Abstract][Full Text] [Related]
10. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
[TBL] [Abstract][Full Text] [Related]
11. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
[TBL] [Abstract][Full Text] [Related]
12. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
Neinaa YME; Lotfy SS; Ghaly NR; Doghaim NN
Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
[TBL] [Abstract][Full Text] [Related]
14. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
[TBL] [Abstract][Full Text] [Related]
15. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.
Hamzavi I; Jain H; McLean D; Shapiro J; Zeng H; Lui H
Arch Dermatol; 2004 Jun; 140(6):677-83. PubMed ID: 15210457
[TBL] [Abstract][Full Text] [Related]
16. Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study.
Khemis A; Fontas E; Moulin S; Montaudié H; Lacour JP; Passeron T
J Invest Dermatol; 2020 Aug; 140(8):1533-1537.e2. PubMed ID: 32004567
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
Poolsuwan P; Churee C; Pattamadilok B
Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
[TBL] [Abstract][Full Text] [Related]
18. DEFB1 gene polymorphisms modify vitiligo extent and response to NB-UVB phototherapy.
Salem RM; Abdelrahman AMN; Abd El-Kareem HM; Seif M
Dermatol Ther; 2021 May; 34(3):e14921. PubMed ID: 33647170
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of using oral methotrexate with phototherapy in the treatment of vitiligo in comparison with single phototherapy treatment: A double-blinded randomized controlled trial.
Lajevardi V; Hosseini ZSS; Heidari S
Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):657-662. PubMed ID: 37859524
[TBL] [Abstract][Full Text] [Related]
20. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison.
Eşme P; Gür Aksoy G; Elçin G
Dermatol Surg; 2019 Dec; 45(12):1627-1634. PubMed ID: 30829772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]